Cargando…

Focal therapy for prostate cancer: what is really needed to move from investigational to valid therapeutic alternative?—a narrative review

BACKGROUND AND OBJECTIVE: The most widely accepted therapeutic alternatives for men with intermediate risk prostate cancer (PCa) are mainly represented by whole gland therapies such as surgery or radiotherapy. However, these treatments can carry in some cases profound functional side effects. With t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pellegrino, Antony, Cirulli, Giuseppe O., Mazzone, Elio, Barletta, Francesco, Scuderi, Simone, de Angelis, Mario, Rosiello, Giuseppe, Gandaglia, Giorgio, Montorsi, Francesco, Briganti, Alberto, Stabile, Armando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358522/ https://www.ncbi.nlm.nih.gov/pubmed/35957731 http://dx.doi.org/10.21037/atm-22-50

Ejemplares similares

Prostate Cancer: Is There Still a Role for Systematic Biopsies? Yes
por: Gandaglia, Giorgio, et al.
Publicado: (2022)

Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy: Extended, of Course
por: Gandaglia, Giorgio, et al.
Publicado: (2022)

Implementation of 4Kscore as a Secondary Test Before Prostate Biopsy: Impact on US Population Trends for Prostate Cancer
por: Scuderi, Simone, et al.
Publicado: (2023)

Active surveillance should not be routinely considered in ISUP grade group 2 prostate cancer
por: Gandaglia, Giorgio, et al.
Publicado: (2023)

Anastomotic leaks and catheter time after salvage robot-assisted radical prostatectomy
por: Bandini, Marco, et al.
Publicado: (2018)

An Explanatory Case on the Limitations of Lymph Node Staging in Recurrent Prostate Cancer
por: Bandini, Marco, et al.
Publicado: (2017)

Comment on ‘Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome’
por: Dell'Oglio, Paolo, et al.
Publicado: (2017)

Focal therapy for prostate cancer – index lesion treatment vs. hemiablation. A matter of definition
por: Stabile, Armando, et al.
Publicado: (2019)

Re: Neal D. Shore, Joseph Renzulli, Neil E. Fleshner, et al. Active Surveillance plus Enzalutamide Monotherapy vs Active Surveillance Alone in Patients with Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial. JAMA Oncol 2022;8:1128–36: Let’s Not Go Back in Time! What Have We Learned in the Treatment of Localized Prostate Cancer? Applicability of the ENACT Randomized Clinical Trial in Clinical Practice
por: Gómez Rivas, Juan, et al.
Publicado: (2022)

Penile rehabilitation after radical prostatectomy: does it work?
por: Gandaglia, Giorgio, et al.
Publicado: (2015)

The Learning Curve for Radical Nephrectomy for Kidney Cancer: Implications for Surgical Training
por: Larcher, Alessandro, et al.
Publicado: (2023)

Grade and stage misclassification in intermediate unfavorable‐risk prostate cancer radiotherapy candidates
por: Sorce, Gabriele, et al.
Publicado: (2022)

Has the COVID-19 outbreak changed the way we are treating prostate cancer? An EAU – YAU Prostate Cancer Working Group multi-institutional study
por: Zattoni, Fabio, et al.
Publicado: (2021)

Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer
por: Bravi, Carlo A., et al.
Publicado: (2022)

Racial differences in the distribution of bladder cancer metastases: a population-based analysis
por: Rosiello, Giuseppe, et al.
Publicado: (2020)

Primary lymphomas of the genitourinary tract: A population-based study
por: Palumbo, Carlotta, et al.
Publicado: (2020)

The Impact of PSMA-PET on Oncologic Control in Prostate Cancer Patients Who Experienced PSA Persistence or Recurrence
por: Bianchi, Lorenzo, et al.
Publicado: (2022)

PSMA-PET Guided Treatment in Prostate Cancer Patients with Oligorecurrent Progression after Previous Salvage Treatment
por: Bianchi, Lorenzo, et al.
Publicado: (2023)

Differences in Cancer-Specific Mortality after Trimodal Therapy for T2N0M0 Bladder Cancer according to Histological Subtype
por: Barletta, Francesco, et al.
Publicado: (2022)

Postprostatectomy Erectile Dysfunction: A Review
por: Capogrosso, Paolo, et al.
Publicado: (2016)

Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol
por: Beyer, Katharina, et al.
Publicado: (2021)

Focal Therapy for Prostate Cancer: Complications and Their Treatment
por: Rakauskas, Arnas, et al.
Publicado: (2021)

Moving Immune Checkpoint Inhibitors to Early Non-Small Cell Lung Cancer: A Narrative Review
por: Viscardi, Giuseppe, et al.
Publicado: (2022)

Enhanced recovery after surgery (ERAS) in radical cystectomy patients: from consensus to evidences
por: Moschini, Marco, et al.
Publicado: (2019)

Does texting while walking really affect gait in young adults?
por: Agostini, Valentina, et al.
Publicado: (2015)

A Systematic Review to Evaluate Patient-Reported Outcome Measures (PROMs) for Metastatic Prostate Cancer According to the COnsensus-Based Standard for the Selection of Health Measurement INstruments (COSMIN) Methodology
por: Ratti, Maria Monica, et al.
Publicado: (2022)

The ontogenesis of narrative: from moving to meaning
por: Delafield-Butt, Jonathan T., et al.
Publicado: (2015)

Expression-profiling of apoptosis induced by ablation of the long ncRNA TRPM2-AS in prostate cancer cell
por: Lavorgna, Giovanni, et al.
Publicado: (2014)

Prevention and management of post prostatectomy erectile dysfunction
por: Salonia, Andrea, et al.
Publicado: (2015)

Focal Active Colitis: What Are Its Clinical Implications? A Narrative Review
por: Sinagra, Emanuele, et al.
Publicado: (2023)

Predicting the probability of pT3 or higher pathological stage at radical prostatectomy: COVID19-specific considerations
por: Nocera, Luigi, et al.
Publicado: (2022)

The Rare, Unexpected Condition of a Twisted Leiomyoma in Mayer-Rokitansky-Küster-Hauser (MRKH) Syndrome: Etiopathogenesis, Diagnosis and Management. Our Experience and Narrative Review of the Literature
por: Romano, Federico, et al.
Publicado: (2021)

Ultraviolet Light Protection: Is It Really Enough?
por: Farris, Patricia K., et al.
Publicado: (2022)

How stories and narrative move the heart—literally
por: Beans, Carolyn
Publicado: (2022)

Advanced Imaging Analysis in Prostate MRI: Building a Radiomic Signature to Predict Tumor Aggressiveness
por: Damascelli, Anna, et al.
Publicado: (2021)

Metabolic Syndrome and Benign Prostatic Hyperplasia: Evidence of a Potential Relationship, Hypothesized Etiology, and Prevention
por: Abdollah, Firas, et al.
Publicado: (2011)

Metabolomics: moving towards personalized medicine
por: Baraldi, Eugenio, et al.
Publicado: (2009)

Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature
por: Mari, Andrea, et al.
Publicado: (2017)

You need a rocket!: a reality check to really get your life moving
por: Ayles, Martin B
Publicado: (2016)

Measuring Nepotism through Shared Last Names: Are We Really Moving from Opinions to Facts?
por: Ferlazzo, Fabio, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5u6qdjj1fad8np7c49r2hs0ah5